Skip to main content
Top
Published in: BMC Cancer 1/2021

Open Access 01-12-2021 | Glioblastoma | Research

Prognostic significance of the postoperative prognostic nutritional index in patients with glioblastoma: a retrospective study

Authors: Yoon Jung Kim, Hyongmin Oh, Sang Jin Lee, Kyung-Min Kim, Ho Kang, Chul-Kee Park, Hee-Pyoung Park

Published in: BMC Cancer | Issue 1/2021

Login to get access

Abstract

Background

The prognostic nutritional index (PNI) reflects immunonutritional status. We evaluated the effects of postoperative PNI and perioperative changes in the PNI on overall survival (OS) in glioblastoma (GBM) patients.

Methods

Demographic, laboratory, and clinical data were retrospectively collected from 335 GBM patients. Preoperative and postoperative PNIs were calculated from serum albumin concentration and lymphocyte count, which were measured within 3 weeks before surgery and 1 month after surgery. Patients were classified into high (n = 206) or low (n = 129) postoperative PNI groups according to the postoperative PNI cutoff value and further classified into four groups according to the cutoff values of the preoperative and postoperative PNIs, as follows: Group HH (both high PNIs, n = 92), Group HL (high preoperative and low postoperative PNI, n = 70), Group LH (low preoperative and high postoperative PNI, n = 37), and Group LL (both low PNIs, n = 136).

Results

The median OS was significantly longer in the high postoperative PNI (PNI ≥ 50.2) group than the low postoperative PNI (PNI < 50.2) group (24.0 vs. 15.0 months, p <  0.001). In multivariate analysis, high postoperative PNI was a significant predictor of OS. OS was significantly longer in Group HH than in Group LL and seemed longer in Group HH than in Group HL and in Group LH than in Group LL. OS was not different between Groups HH and LH or between Groups HL and LL.

Conclusions

High postoperative PNI was associated with improved OS and perioperative changes in PNI may provide additional important information for prognostic prediction in GBM patients.
Appendix
Available only for authorised users
Literature
2.
13.
go back to reference Kim YS, Kim SH, Cho J, Kim JW, Chang JH, Kim DS, et al. MGMT Gene Promoter Methylation as a Potent Prognostic Factor in Glioblastoma Treated With Temozolomide-Based Chemoradiotherapy: A Single-Institution Study. Int J Radiat Oncol Biol Phys. 2012;84(3):661–7.CrossRef Kim YS, Kim SH, Cho J, Kim JW, Chang JH, Kim DS, et al. MGMT Gene Promoter Methylation as a Potent Prognostic Factor in Glioblastoma Treated With Temozolomide-Based Chemoradiotherapy: A Single-Institution Study. Int J Radiat Oncol Biol Phys. 2012;84(3):661–7.CrossRef
16.
go back to reference Onodera T, Goseki N, Kosaki G. prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi. 1984;85(9):1001–5.PubMed Onodera T, Goseki N, Kosaki G. prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi. 1984;85(9):1001–5.PubMed
27.
go back to reference Shibutani M, Maeda K, Nagahara H, Ohtani H, Iseki Y, Ikeya T, et al. The prognostic significance of the postoperative prognostic nutritional index in patients with colorectal cancer. BMC Cancer. 2015;15(1):521. Shibutani M, Maeda K, Nagahara H, Ohtani H, Iseki Y, Ikeya T, et al. The prognostic significance of the postoperative prognostic nutritional index in patients with colorectal cancer. BMC Cancer. 2015;15(1):521.
38.
go back to reference Nabors LB. Management of Gliomas: Individualized Treatment Options. J Natl Compr Cancer Netw. 2020;18(7.5):985–8.CrossRef Nabors LB. Management of Gliomas: Individualized Treatment Options. J Natl Compr Cancer Netw. 2020;18(7.5):985–8.CrossRef
39.
go back to reference Guerrero Orriach JL, Raigon Ponferrada A, Malo Manso A, Herrera Imbroda B, Escalona Belmonte JJ, Ramirez Aliaga M, et al. Anesthesia in combination with Propofol increases disease-free survival in bladder Cancer patients who undergo radical tumor cystectomy as compared to inhalational anesthetics and opiate-based analgesia. Oncology. 2020;98(3):161–7. https://doi.org/10.1159/000504807.CrossRefPubMed Guerrero Orriach JL, Raigon Ponferrada A, Malo Manso A, Herrera Imbroda B, Escalona Belmonte JJ, Ramirez Aliaga M, et al. Anesthesia in combination with Propofol increases disease-free survival in bladder Cancer patients who undergo radical tumor cystectomy as compared to inhalational anesthetics and opiate-based analgesia. Oncology. 2020;98(3):161–7. https://​doi.​org/​10.​1159/​000504807.CrossRefPubMed
Metadata
Title
Prognostic significance of the postoperative prognostic nutritional index in patients with glioblastoma: a retrospective study
Authors
Yoon Jung Kim
Hyongmin Oh
Sang Jin Lee
Kyung-Min Kim
Ho Kang
Chul-Kee Park
Hee-Pyoung Park
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2021
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-021-08686-8

Other articles of this Issue 1/2021

BMC Cancer 1/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine